Therapy for vasculitic neuropathies

Current Treatment Options in Neurology

Volumn 8, Issue 2, 2006, Pages 105-117

  Gorson, Kenneth C ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALLOPURINOL; ALPHA INTERFERON; AMPHOTERICIN B; ANTIEMETIC AGENT; AZATHIOPRINE; CHLORAMPHENICOL; COLCHICINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FUROSEMIDE; IMMUNOGLOBULIN; INFLIXIMAB; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLAMINE; PHENOBARBITAL; PHENYTOIN; PREDNISONE; RIFAMPICIN; RITUXIMAB; STEROID; SUXAMETHONIUM; TETRACYCLINE; UNINDEXED DRUG; ZIDOVUDINE;

ABDOMINAL PAIN; ADD ON THERAPY; ALOPECIA; AMENORRHEA; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ANOREXIA; ARTHRALGIA; ASEPTIC MENINGITIS; ASEPTIC NECROSIS; AXONAL INJURY; BACKACHE; BONE MARROW SUPPRESSION; CANCER RISK; CATARACT; CELL INFILTRATION; CHILL; CHURG STRAUSS SYNDROME; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONNECTIVE TISSUE DISEASE; DEPRESSION; DIABETES MELLITUS; DIABETIC NEUROPATHY; DIARRHEA; DISEASE CLASSIFICATION; DISEASE EXACERBATION; DIZZINESS; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG CONTRAINDICATION; DRUG COST; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG PULSE THERAPY; DRUG USE; DYSPNEA; ECZEMA; EDEMA; FATIGUE; FEVER; FLU LIKE SYNDROME; FLUSHING; GASTROINTESTINAL HEMORRHAGE; HEADACHE; HEMORRHAGIC CYSTITIS; HEPATITIS B; HUMAN; HYPERTENSION; HYPERVISCOSITY SYNDROME; HYPOKALEMIA; HYPOTENSION; HYPOTHYROIDISM; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; INFECTION SENSITIVITY; INFERTILITY; INFLAMMATORY CELL; INJECTION SITE REACTION; INSOMNIA; ISCHEMIA; KIDNEY FAILURE; LEG PAIN; LEUKEMIA; LEUKOPENIA; LIVER TOXICITY; LUNG DISEASE; LYMPHOMA; MENTAL INSTABILITY; MONOTHERAPY; MYALGIA; MYOPATHY; NAUSEA; NERVE BIOPSY; NEUROPATHY; NEUTROPENIA; OSTEOPOROSIS; PANCREATITIS; PARANEOPLASTIC SYNDROME; PERIPHERAL NEUROPATHY; PHARYNGITIS; PLASMAPHERESIS; POLYARTERITIS NODOSA; PRURITUS; RASH; RELAPSE; REMISSION; REVIEW; RIGOR; SIDE EFFECT; SINUSITIS; STOMACH IRRITATION; STOMATITIS; SYSTEMIC VASCULITIS; TERATOGENICITY; THORAX PAIN; UPPER RESPIRATORY TRACT INFECTION; URINARY TRACT INFECTION; URTICARIA; VASCULITIS; VOMITING; WOUND HEALING IMPAIRMENT;

EID: 33344458635     PISSN: 10928480     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11940-006-0002-1     Document Type: Review

References (72)

1. Jennette JC, Falk AJ, Andrassy K, et al.: Nomenclature of systemic vasculitides: proposal of an international consensus conference. Arthritis Rheum 1994, 37:187-192.
2. Bradley WG, Chad D, Verghese JP, et al.: Painful lumbosacral plexopathy with elevated erythrocyte sedimentation rate: a treatable inflammatory syndrome. Ann Neurol 1984, 15:457-464.
3. Dyck PJ, Engelstad J, Norell J, Dyck PJ: Microvasculitis in non-diabetic lumbosacral radiculoplexus neuropathy (LSRPN): similarity to the diabetic variety (DLSRPN). J Neuropathol Exp Neurol 2000, 59:525-538.
4. Dyck PJ, Windebank AJ: Diabetic and nondiabetic lumbosacral radiculoplexus neuropathies: new insights into pathophysiology and treatment. Muscle Nerve 2002, 25:477-491.
5. Collins MP, Kissel JT: Vasculitis of the peripheral nervous system. In Neurological Therapeutics: Principles and Practice. Edited by Noseworthy JH. London: Martin Dunitz, 2003:2078-2110.
6. Wees SJ, Sunwoo IN, Oh SJ: Sural nerve biopsy in systemic necrotizing vasculitis. Am J Med 1981, 71:525-532.
7. Seo JH, Ryan HF, Claussen GC, et al.: Sensory neuropathy in vasculitis: a clinical, pathologic, and electrophysiologic study. Neurology 2004, 63:874-878.
8. Said G, Lacroix C: Primary and secondary vasculitic neuropathy. J Neurol 2005, 252:633-641.
9. Chia L, Fernandez A, Lacroix C, et al.: Contribution of nerve biopsy findings to the diagnosis of disabling neuropathy in the elderly. A retrospective review of 100 consecutive patients. Brain 1996, 119:1091-1098.
10. Rosenbaum R: Neuromuscular complications of connective tissue diseases. Muscle Nerve 2001, 24:154-169.
11. Puechal X, Said G, Hilliquin P, et al.: Peripheral neuropathy with necrotizing vasculitis in rheumatoid arthritis. A clinicopathologic and prognostic study of thirty-two patients. Arthritis Rheum 1995, 38:1618-1629.
12. Khella SL, Frost S, Hermann GA, et al.: Hepatitis C infection, cryoglobulinemia, and vasculitic neuropathy. Treatment with interferon alfa: case report and literature review. Neurology 1995, 45:407-411.
13. Said G, Lacroix C, Plante-Bordeneuve V, et al.: Nerve granulomas and vasculitis in sarcoid peripheral neuropathy: a clinicopathological study of 11 patients. Brain 2002, 125:264-275.
14. McCombe PA, McLead JG, Pollard JD, et al.: Peripheral sensorimotor and autonomic neuropathy associated with systemic lupus erythematosus. Clinical, pathological, and immunological features. Brain 1987, 110:533-549.
15. Mori K, Iijima M, Koike H, et al.: The wide spectrum of clinical manifestations in Sjogren's syndrome-associated neuropathy. Brain 2005, 128:2518-2534.
16. Guillevin L, Lhote F, Cohen P, et al.: Polyarteritis nodosa related to hepatitis B virus: a prospective study with long-term observation of 41 patients. Medicine 1995, 74:238-253.
17. Cohen JA, Wilborn SL, Rector WG Jr, Golitz LE: Mononeuropathy multiplex associated with acute hepatitis B infection. Muscle Nerve 1990, 13:195-198.
18. Nemni R, Sanvito L, Quattrini A, et al.: Peripheral neuropathy in hepatitis C virus infection with and without cryoglobulinaemia. J Neurol Neurosurg Psychiatry 2003, 74:1267-1271.
19. Kanai K, Kuwabara S, Mori M, et al.: Leukocytoclasticvasculitic neuropathy associated with chronic Epstein-Barr virus infection. Muscle Nerve 2003, 27:113-116.
20. Somer T, Finegold SM: Vasculitides associated with infections, immunization, and antimicrobial drugs. Clin Infect Dis 1995, 20:1010-1036.
21. Bradley WG, Verma A: Painful vasculitic neuropathy in HIV-1 infection: relief of pain with prednisone therapy. Neurology 1996, 47:1446-1451.
22. Ferrari S, Lanzafame M, Faggian F, et al.: Painful neuropathy vasculitis in 2 patients with long-standing human immunodeficiency virus-1 infection. Scand J Infect Dis 2004, 36:392-393.
23. Oh SJ: Paraneoplastic vasculitis of the peripheral nervous system. Neurol Clin 1997, 15:849-863.
24. Doyle MK, Cuellar ML: Drug-induced vasculitis. Expert Opin Drug Saf 2003, 2:401-409.
25. Bouche P, Leger JM, Travers MA, et al.: Peripheral neuropathy in systemic vasculitis: clinical and electrophysiologic study of 22 patients. Neurology 1986, 36:1598-1602.
26. Olney RK: Neuropathies associated with connective tissue disease. Semin Neurol 1998, 18:63-72.
27. Briemberg HR, Levin K, Amato AA: Multifocal conduction block in peripheral nerve vasculitis. J Clin Neuromusc Dis 2002, 3:153-158.
28. Kissel JT, Collins MP, Mendell JR: Vasculitic neuropathy. In Diagnosis and Management of Peripheral Nerve Disorders. Edited by Mendell JR, Kissel JT, Cornblath DR. New York: Oxford University Press; 2001:202-232.
29. Collins MP, Mendell JR, Periquet MI, et al.: Superficial peroneal nerve/peroneus brevis muscle biopsy in vasculitic neuropathy. Neurology 2000, 55:636-643.
30. Pagnoux C, Guillevin L: Peripheral neuropathy in systemic vasculitides. Curr Opin Rheumatol 2005, 17:41-48.
31. Collins MP, Periquet MI: Nonsystemic vasculitic neuropathy. Curr Opin Neurol 2004, 17:587-598.
32. Kararizou E, Davaki P, Karandreas N, et al.: Nonsystemic vasculitic neuropathy: a clinicopathological study of 22 cases. J Rheumatol 2005, 32:853-858.
33. Collins MP, Periquet MI, Mendell JR, et al.: Nonsystemic vasculitic neuropathy: insights from a clinical cohort. Neurology 2003, 61:623-630.
34. Dyck PJB, Norell JE, Dyck PJ: Microvasculitis and ischemia in diabetic lumbosacral radiculoplexus neuropathy. Neurology 1999, 53:2113-2121.
35. Kelkar P, Masood M, Parry GJ: Distinctive pathologic findings in proximal diabetic neuropathy (diabetic amyotrophy). Neurology 2000, 55:83-88.
36. Said G, Lacroix C, Lozeron P, et al.: Inflammatory vasculopathy in multifocal diabetic neuropathy. Brain 2003, 126:376-385.
37. Llewelyn JG, Thomas PK, King RH: Epineurial microvasculitis in proidmal diabetic neuropathy. J Neurol 1998, 245:159-165.
38. Adu D, Pall A, Luqmani RA, et al.: Controlled trial of pulse versus continuous prednisolone and cyclophosphamide in the treatment of vasculitis. Q J Med 1997, 90:401-409.
39. Guillevin L, Cordier JF, Lhote F, et al.: A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized Wegener's granulomatosis. Arthritis Rheum 1997, 40:2187-2198.
40. Jayne D, Rasmussen N, Andrassy K, et al.: A randomized trial of maintenance therapy for vasculitis associated with anti-neutrophil cytoplasmic autoantibodies. N Engl J Med 2003, 349:36-44.
41. Levy Y, Uziel Y, Zandman GG, et al.: Intravenous immunoglobulins in peripheral neuropathy associated with vasculitis. Ann Rheum Dis 2003, 62:1221-1223.
42. Tsurikisawa N, Taniguchi M, Saito H, et al.: Treatment of Churg-Strauss syndrome with high-dose intravenous immunoglobulin. Ann Allergy Asthma Immunol 2004, 92:80-87.
43. Zaja F, De Vita S, Mazzaro C, et al.: Efficacy and safety of rituximab in type II mixed cryoglobulinemia. Blood 2003, 101:3827-3834.
44. Uthman I: Pharmacological therapy of vasculitis: an update. Curr Opin Pharmacol 2004, 4:177-182.
45. Mang R, Ruzicka T, Stege H: Therapy for severe necrotizing vasculitis with infliximab. J Am Acad Dermatol 2004, 51:321-322.
46. Chandesris MO, Gayet S, Schleinitz N, et al.: Infliximab in the treatment of refractory vasculitis secondary to hepatitis C-associated mixed cryoglobulinaemia. Rheumatology 2004, 43:532-533.
47. Hellmich B, Gross WL: Recent progress in the pharmacotherapy of Churg-Strauss syndrome. Expert Opin Pharmacother 2004, 5:25-35.
48. Pockros PJ, Carithers R, Desmond P, et al.: PEGASYS International Study Group. Efficacy and safety of two-dose regimens of peginterferon alpha-2a compared with interferon alpha-2a in chronic hepatitis C: a multicenter, randomized controlled trial. Am J Gastroenterol 2004, 99:1298-1305.
49. Mazzaro C, Zorat F, Caizzi M, et al.: Treatment with peg-interferon alfa-2b and ribavirin of hepatitis C virus-associated mixed cryoglobulinemia: a pilot study. J Hepatol 2005, 42:632-638.
50. Boonyapisit K, Katirji B: Severe exacerbation of hepatitis C-associated vasculitic neuropathy following treatment with interferon alpha: a case report and literature review. Muscle Nerve 2002, 25:909-913.
51. Valbonesi M, Montani F, Mosconi L, et al.: Plasmapheresis and cytotoxic drugs for mixed cryoglobulinemia. Haematologia 1984, 17:341-351.
52. Wulff EA, Wang AK, Simpson DM: HIV-associated peripheral neuropathy: epidemiology, pathophysiology and treatment. Drugs 2000, 59:1251-1260.
53. Dyck PJ, Benstead T J, Conn DL, et al.: Nonsystemic vasculitic neuropathy. Brain 1987, 110:843-853.
54. Griffin JW: Vasculitic neuropathies. Rheum Dis Clin North Am 2001, 27:751-760.
55. Krendel DA, Zacharias A, Younger DS: Autoimmune diabetic neuropathy. Neurol Clin 1997, 15:959-971.
56. Pascoe MK, Low PA, Windebank AJ, Litchy WJ: Subacute diabetic proximal neuropathy. Mayo Clin Proc 1997, 72:1123-1132.
57. Kilfoyle D, Kelkar P, Parry GJ: Pulsed methylprednisolone is safe and effective treatment for diabetic amyotrophy. J Clin Neuromusc Dis 2003, 4:168-170.
58. Dyck PJB, O'Brien PC, Bosch EP, et al.: Results of a controlled trial of IV methylprednisolone in diabetic lumbosacral radiculoplexus neuropathy (DLRPN): a preliminary indication of efficacy. J Peripher Nerv Syst 2005, 10(Suppl 1):21.
59. De Groot K, Rasmussen N, Bacon PA, et al.: Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum 2005, 52:2461-2469.
60. Guillevin L, Mahr A, Cohen P, et al.: Vasculitis Study Group. Short-term corticosteroids then lamivudine and plasma exchanges to treat hepatitis B virus-related polyarteritis nodosa. Arthritis Rheum 2004, 51:482-487.
61. Murai H, Inaba S, Kira J, et al.: Hepatitis C virus associated cryoglobulinemic neuropathy successfully treated with plasma exchange. Artif Organs 1995, 19:334-338.
62. Gorson KC, Amato AA, Ropper AH: Efficacy of mycophenolate mofetil in patients with chronic immune demyelinating polyneuropathy. Neurology 2004, 63:715-717.
63. Nowack R, Gobel U, Klooker P, et al.: Mycophenolate mofetil for maintenance therapy of Wegener's granulomatous and microscopic polyangiitis: a pilot study of 11 patients with renal involvement. J Am Soc Nephrol 1999, 10:1965-1971.
64. Langford CA, Talar-Williams C, Sneller MC: Mycophenolate mofetil for remission maintenance in the treatment of Wegener's granulomatosis. Arthritis Rheum 2004, 51:278-283.
65. Chambers SA, Isenberg D: Anti-B cell therapy (rituximab) in the treatment of autoimmune diseases. Lupus 2005, 14:210-214.
66. Renaud S, Gregor M, Fuhr P, et al.: Rituximab in the treatment of polyneuropathy associated with anti-MAG antibodies. Muscle Nerve 2003, 27:611-615.
67. Eriksson P: Nine patients with anti-neutrophil cytoplasmic antibody-positive vasculitis successfully treated with rituximab. J Intern Med 2005, 257:540-548.
68. Omdal R, Wildhagen K, Hansen T, et al.: Anti-CD20 therapy of treatment-resistant Wegener's granulomatosis: favourable but temporary response. Scand J Rheumatol 2005, 34:229-232.
69. Lamprecht P, Lerin-Lozano C, Merz H, et al.: Rituximab induces remission in refractory HCV associated cryoglobulinaemic vasculitis. Ann Rheum Dis 2003, 62:1230-1233.
70. Booth A, Harper L, Hammad T, et al.: Prospective study of TNF alpha blockade with infliximab in anti-neutrophil cytoplasmic antibody-associated systemic vasculitis. J Am Soc Nephrol 2004, 15:717-721.
71. van der Bijl AE, Allaart CF, Van Vugt J, et al.: Rheumatoid vasculitis treated with infliximab. J Rheumatol 2005, 32:1607-1609.
72. Al-Bishri J, le Riche N, Pope JE: Refractory polyarteritis nodosa successfully treated with infliximab. J Rheumatol 2005, 32:1371-1373.